Firms
Theme

AXTA

Axalta Coating Systems Ltd. · NYSE

News

11 latest

Zacks Investment Research

Axalta Coating Systems (AXTA) Earnings Expected to Grow: Should You Buy?

Axalta Coating Systems is expected to report Q3 2026 earnings of $0.71 per share (up 6% YoY) with revenues of $1.33 billion (up 3.6% YoY) on October 29. The company has a positive Earnings ESP of +0.30% with a Zacks Rank #3 (Hold), suggesting it is likely to beat consensus estimates. The stock has beaten EPS estimates in 3 of the last 4 quarters, with the most recent quarter delivering a +10.77% surprise.

Zacks Investment Research

AXTA vs. HWKN: Which Stock Should Value Investors Buy Now?

A comparison of two chemical-specialty sector stocks reveals that Axalta Coating Systems (AXTA) presents a better value opportunity than Hawkins (HWKN). AXTA has a Zacks Rank of #2 (Buy) with a Value grade of B, supported by a lower forward P/E ratio of 12.61 and PEG ratio of 1.53. In contrast, HWKN carries a Zacks Rank of #4 (Sell) with a Value grade of D, featuring a higher forward P/E of 32.18 and PEG ratio of 2.68, making it less attractive to value investors.

Zacks Investment Research

Will Axalta Coating Systems (AXTA) Beat Estimates Again in Its Next Earnings Report?

Axalta Coating Systems (AXTA) has demonstrated a strong earnings-beat streak, surpassing estimates by an average of 11.38% over the last two quarters. With a positive Earnings ESP of +0.51% and a Zacks Rank #2 (Buy) rating, analysts expect the company to potentially beat consensus estimates again in its upcoming earnings report scheduled for October 29, 2026. Stocks combining positive Earnings ESP with a strong Zacks Rank historically beat estimates nearly 70% of the time.

GlobeNewswire Inc.

Axalta Schedules Third Quarter 2026 Earnings Conference Call

Axalta Coating Systems announced it will release its third quarter 2026 financial results on October 29, 2026, at 6 a.m. ET, followed by a conference call at 8 a.m. ET with CEO Chris Villavarayan and CFO Carl Anderson to discuss the company's financial performance.

Zacks Investment Research

Bears are Losing Control Over Axalta Coating Systems (AXTA), Here's Why It's a 'Buy' Now

Axalta Coating Systems (AXTA) has formed a hammer chart pattern after a 11.5% decline over four weeks, signaling a potential trend reversal. The technical indicator is supported by fundamental strength, including upward earnings estimate revisions from Wall Street analysts and a Zacks Rank #2 (Buy) rating, suggesting the stock could be positioned for a turnaround.

Zacks Investment Research

AXTA or HWKN: Which Is the Better Value Stock Right Now?

In a comparison of two Chemical - Specialty stocks, Axalta Coating Systems (AXTA) emerges as the more attractive option for value investors. AXTA holds a Zacks Rank #2 (Buy) with a Value grade of B, featuring a forward P/E of 12.42 and PEG ratio of 1.51. Hawkins (HWKN) has a Zacks Rank #4 (Sell) with a Value grade of D, showing a forward P/E of 31.38 and PEG ratio of 2.62, indicating it is relatively overvalued.

Mentions AXTA

Zacks Investment Research

Loop Industries, Inc. (LOOP) Reports Q2 Loss, Misses Revenue Estimates

Loop Industries reported a Q2 loss of $0.06 per share, missing consensus estimates of $0.05 loss, with revenues of only $0.12 million versus expectations. The company has underperformed the market by 65.8% year-to-date and holds a Zacks Rank #3 (Hold) rating. The Chemical - Specialty industry ranks in the bottom 24% of sectors.

Zacks Investment Research

BASFY Launches GLYTHERMIN to Meet Cooling Needs of Data Centers

BASF has launched its GLYTHERMIN DC and PG coolant product lines to address the growing thermal management needs of AI-driven data centers. As server rack power density increases with heat loads exceeding 150 kW, direct liquid cooling demand is rising. The products qualify as NVIDIA DSX Ready Coolants and leverage BASF's expertise in heat transfer fluids and corrosion protection.

Zacks Investment Research

Nucor Expands Utility Towers Capacity With $105M Investment

Nucor Corporation announced a $105 million expansion of its Crawfordsville, Indiana utility structures facility, subject to regulatory approvals. The project will add over 120,000 square feet of manufacturing space with advanced automation and create 100 new jobs with average annual wages of $87,500. The expansion supports electric grid modernization and increasing electricity demands.

Zacks Investment Research

Kronos Worldwide Shares Surge 72% YTD: What's Driving the Rally?

Kronos Worldwide (KRO) has seen its shares surge 72.2% year-to-date, driven by a 16% increase in titanium dioxide sales volumes, market-share gains, and improving profitability. The company is implementing cost-reduction and pricing initiatives to support margin expansion, while maintaining strong liquidity with $261 million in revolving credit availability.

Zacks Investment Research

Here's Why You Should Add Cabot Stock to Your Portfolio Now

Cabot Corporation (CBT) is strengthening its long-term growth prospects through capital-efficient battery materials expansion and improved earnings guidance. The company targets $40 million in battery materials EBITDA for fiscal 2026, supported by rising global battery demand. With $278 million in nine-month operating cash flow and $30 million in targeted cost savings, CBT is well-positioned for sustained growth.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $AXTA · 0 threads

Sign in to post on $AXTA

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev